Compass Therapeutics Correlations

CMPX Stock

USD 6.00 0.11 1.87%

The current 90-days correlation between Compass Therapeutics and Fulcrum Therapeutics is -0.01 (i.e., Good diversification). The correlation of Compass Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Compass Therapeutics Correlation With Market

Poor diversification

The correlation between Compass Therapeutics and DJI is 0.71 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Compass Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Moving together with Compass Stock

0.73	GXEA	Galapagos NV	Pair Corr
0.7	8VP1	AVRICORE HEALTH INC	Pair Corr
0.7	CMB	Cambium Bio Earnings Call Tomorrow	Pair Corr
0.62	VALN	Valneva SE ADR	Pair Corr
0.79	DNLI	Denali Therapeutics Earnings Call This Week	Pair Corr
0.86	DNTH	Dianthus Therapeutics	Pair Corr
0.89	6C1	CytomX Therapeutics	Pair Corr
0.8	DRTS	Alpha Tau Medical	Pair Corr
0.78	DSGN	Design Therapeutics	Pair Corr
0.85	0P6S	Bayer AG NA Earnings Call Next Week	Pair Corr
0.87	DVAX	Dynavax Technologies	Pair Corr

Moving against Compass Stock

0.73	OSE	OSE Pharma SA	Pair Corr
0.73	RAC	Race Oncology	Pair Corr
0.45	VCYT	Veracyte Earnings Call Tomorrow	Pair Corr
0.33	VCEL	Vericel Corp Ord Earnings Call This Week	Pair Corr
0.67	DTIL	Precision BioSciences	Pair Corr
0.48	DRMA	Dermata Therapeutics	Pair Corr
0.48	CDIOW	Cardio Diagnostics	Pair Corr
0.33	DXB	Dimerix	Pair Corr
0.86	BIM	Biomerieux SA Earnings Call This Week	Pair Corr
0.8	IGS1	India Globalization	Pair Corr
0.73	VKTX	Viking Therapeutics	Pair Corr
0.71	DWTX	Dogwood Therapeutics	Pair Corr
0.7	DYAI	Dyadic International	Pair Corr
0.45	9OF	BIORESTORATTHERAPDL	Pair Corr

Related Correlations Analysis

	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER
FULC		0.22	-0.21	0.38	0.52	-0.1	0.18	-0.23	0.28	-0.1	FULC
FDMT	0.22		-0.62	0.16	0.29	0.26	0.27	-0.12	-0.24	-0.68	FDMT
OCGN	-0.21	-0.62		-0.22	-0.53	0.04	-0.17	0.28	0.41	0.4	OCGN
BCYC	0.38	0.16	-0.22		0.75	0.02	0.82	-0.49	0.15	-0.04	BCYC
GOSS	0.52	0.29	-0.53	0.75		-0.19	0.59	-0.54	-0.01	-0.22	GOSS
LXRX	-0.1	0.26	0.04	0.02	-0.19		0.15	0.52	-0.17	-0.25	LXRX
MNPR	0.18	0.27	-0.17	0.82	0.59	0.15		-0.29	0.15	-0.1	MNPR
CRVS	-0.23	-0.12	0.28	-0.49	-0.54	0.52	-0.29		0.02	-0.01	CRVS
KALV	0.28	-0.24	0.41	0.15	-0.01	-0.17	0.15	0.02		0.3	KALV
OMER	-0.1	-0.68	0.4	-0.04	-0.22	-0.25	-0.1	-0.01	0.3		OMER
	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MNPR	+ 0.82	BCYC
GOSS	+ 0.75	BCYC
MNPR	+ 0.59	GOSS
GOSS	+ 0.52	FULC
CRVS	+ 0.52	LXRX
KALV	+ 0.41	OCGN

High negative correlations

OMER	- 0.68	FDMT
OCGN	- 0.62	FDMT
CRVS	- 0.54	GOSS
GOSS	- 0.53	OCGN
CRVS	- 0.49	BCYC
CRVS	- 0.29	MNPR

Risk-Adjusted Indicators

There is a big difference between Compass Stock performing well and Compass Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compass Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FULC	4.43	0.22	0.00	(0.04)	5.54	(5.13)	7.78	(7.84)	53.80
FDMT	3.66	0.06	0.01	0.17	5.81	(3.58)	7.15	(9.69)	27.09
OCGN	3.79	0.76	0.14	3.31	4.33	(4.35)	7.43	(6.62)	32.50
BCYC	2.75	(0.29)	0.00	(0.12)	0.00	0.00	6.06	(5.88)	14.20
GOSS	4.98	(2.04)	0.00	(0.39)	0.00	0.00	7.66	(7.38)	94.66
LXRX	3.84	(0.02)	0.01	0.08	4.99	(4.86)	9.17	(7.65)	38.53
MNPR	2.92	(0.68)	0.00	(1.17)	0.00	0.00	4.07	(6.48)	19.60
CRVS	6.59	2.76	0.47	(0.31)	3.42	(9.22)	7.35	(7.20)	174.42
KALV	2.94	0.11	0.01	0.49	3.79	(2.83)	6.17	(6.60)	20.72
OMER	4.63	0.80	0.15	1.45	4.18	(5.12)	9.89	(7.14)	87.69

Compass Therapeutics Corporate Management

Susan Kalled	Chief Officer	Profile
Cynthia MD	Chief Officer	Profile
Anna Gifford	Communications Manager	Profile
Karin BA	Senior Operations	Profile
Vered MBA	Pres COO	Profile
MBA JD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC